Method developed to aid antibody drug production

KAOHSIUNG -- A research team from Kaohsiung Medical University has developed a new genomic reconstruction method called antibody locker that can be widely applied to antibody drugs and has huge business potential, according to team leader Cheng Tien-lu.

The new development is expected to aid in constructing more selective “second-generation antibody drugs” to achieve selective target therapy, said Cheng, a professor at the university's Biomedical Science and Environmental Biology Department.

The technique, the first of its kind in the world, can be used to produce drugs to kill cancer cells and can reduce side effects caused by these drugs, said Cheng.